PALM BEACH, Florida, June 4, 2020/ PRNewswire/– According to an post by the National Marijuana Market Association, Nanoemulsions will have an effect in the medical, drink and infused markets in the coming months and years. Active business in the markets this week include: Pressure BioSciences, Inc.(OTCQB: PBIO), Canopy Development Corporation ( NYSE: CGC) (TSX: WEED), HEXO Corp. ( NYSE: HEXO) (TSX: HEXO), Cronos Group Inc. ( NASDAQ: CRON) (TSX: CRON), ycbdMD, Inc. ( NYSE: YCBD).
Another research study by Coherent Marketing Insights included: “There are a number of benefits of nanoemulsion over standard emulsion. One such benefit is the severe micro-droplet size of nanoemulsion with high surface location, which makes them highly efficient as a transport system.
(OTCQB: PBIO) BREAKING NEWS: Pressure BioSciences Announces First Production Build Completely Sold Out for Revolutionary UST System for Processing Hemp-Derived Cannabinoid Oil into Steady, Water-Soluble Nanoemulsions – Pressure BioSciences today announced the invoice of an order for the 12 th and final system set up to be constructed in the Business’s initial production run of its innovative BaroShear ™ K45 processing system. The cannabidiol market is projected to surpass $20 B by 2024 ( Forbes, Might 2019).
Hemp-derived cannabinoids are drawn out from the hemp plant in an oil.
The Business previously announced plans for its very first manufacturing run of twelve (12) BaroShear K45 processing systems with approximated completion times during the 4th quarter of2020 Due to ineffectiveness caused by the COVID-19 pandemic, the Business now believes that all 12 systems will be completed in time for shipment and installation to happen throughout the first quarter of 2021.
Mr. Kenneth F. Micciche, Director of PBI’s UST Program, stated: “The order for the last available BaroShear K45 system from our preliminary production run was received from an amazing young company out of Massachusetts called Canopy CBD Farms, LLC. They utilize only the highest quality hemp biomass available and the newest processing innovations to fulfill or go beyond market standards.
Mr. John Westlake, Founder and President of Canopy CBD Farms, LLC., commented: “Scientific data highly supports the critical understanding that hemp-derived cannabinoid oil requires to be processed into an efficiently water-soluble, long-lasting stable nanoemulsion to accomplish the highest quality hemp-derived cannabinoid items possible.
Mr. Richard T. Schumacher, President and CEO of PBI, commented: “We are extremely gratified and fired up that the initial production run of our BaroShear K45 processing systems has offered out. We are also pleased that an outstanding, up-and-coming company like Canopy CBD Farms was able to take part in and put an order for the last available unit in our very first manufacturing run. We are confident that the BaroShear K45 will differentiate them in the marketplace with a considerable advantage over their competition.” Read this and more news for Pressure BioSciences at: https://www.financialnewsmedia.com/news-pbio/
Other recent developments in the markets include:
Canopy Growth Corporation ( NYSE: CGC) (TSX: WEED.TO) has just recently offered updates on the Business’s 2.0 development products that have introduced into the Canadian recreational market in early 2020, and additional upcoming item releases.
The very first wave of the Business’s ready-to-drink cannabis-infused beverages — Tweed Houndstooth & Soda and Tweed Bakerstreet & Ginger — shipped in March 2020 and April 2020, respectively. Houndstooth & Soda– the very first THC instilled ready-to-drink beverage to strike the Canadian market– garnered favorable early evaluations and strong customer need across the nation, with further deliveries having actually because been sent to provincial boards and retailers to satisfy continuous demand. Canadians can expect to see two additional drinks– Houseplant Grapefruit and Deep Space — readily available through retail and e-commerce platforms within the coming weeks.
A year earlier, the Company updated its medical product packaging to comply with the Cannabis Regulations, resulting in smaller sized product formats.
” We know our medical clients have been awaiting this opportunity to purchase a greater volume of marijuana without excess packaging,” said HEXO CEO and co-founder Sebastien St-Louis “Our Tsunami flower gain from boosted humidity controls for optimum freshness and to promote ideal bud density.”
Cronos Group Inc. ( NASDAQ: CRON) (TSX: CRON.TO) just recently launched its 2020 very first quarter service outcomes. “Cronos Group began 2020 energized and identified to continue to see through our core strategic efforts to drive long-term and sustainable development. This quarter, we moved better to formally getting in the Israeli medical cannabis market with our Cronos Israel operations preparing to sell PEACE NATURALS ™ branded dried flower items to medical patients. The Israeli medical market is a growing channel, and we look forward to serving this market in 2020 and beyond,” stated Mike Gorenstein, CEO of Cronos Group.
” In spite of the difficulties and unpredictability posed by the COVID-19 pandemic, we remain nimble and focused as a business. Our brand portfolio continues to launch ingenious products to customers as we adjust to an online-first circulation design in both the U.S. and Canada
cbdMD, Inc. ( NYSE: YCBD) just recently reported its 2nd financial 2020 quarter ended March 31, 2020 results. “We are pleased to report strong 2nd quarter outcomes, along with supply a mid-quarter update on operations. We reported $ 9.4 million in quarterly net sales, a 67%increase over the same quarter in 2015. Our gross revenue margin remains strong at 67%year-to-date and 70.9%for the quarter. Our overall direct to customer e-commerce sales for the March fiscal quarter were $ 6.8 million or 72%of our total net sales, a boost of $ 2.5 million or 58%from the previous year’s quarter. Our B2B brick and mortar sales were $ 2.6 million or 28%of our total net sales, a boost of $ 1.2 million or 85%from the prior year’s quarter. Direct to consumer e-commerce sales for the 6 months ending March were $136 million or 70%of our total net sales, an increase of $ 8.9 million or 189%from the prior year period. Our B2B traditional sales were $ 5.9 million or 30%of total net sales, an increase of $ 4.5 million or 321%from the previous year period. Our operating expenses for the March quarter were $122 million, of which approximately $665,000 was non-cash expenditures, leading to a money use of $ 4.2 million for the quarter. Year to date our operating expenses were $248 million, of which roughly $ 1.5 million was non-cash costs, resulting in a money usage of around $ 9.1 million for the 6 months ending March 31, 2020,” said Martin Sumichrast, Chairman and co-CEO of the Business.
DISCLAIMER: FN Media Group LLC (FNM), which owns and runs FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination provider, which shares electronic info through numerous online media channels. FNM is NOT associated in any way with any business mentioned herein. FNM and its associated companies are a news dissemination solutions service provider and are NOT a registered broker/dealer/analyst/ advisor, holds no financial investment licenses and may NOT offer, provide to offer or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or suggestion to buy, sell or hold securities. The product in this release is planned to be strictly educational and is NEVER to be interpreted or interpreted as research study material. All readers are highly advised to carry out research and due diligence on their own and consult a certified financial professional prior to considering any level of buying stocks. All material consisted of herein is republished material and details which were formerly disseminated by the companies pointed out in this release. FNM is not accountable for any investment decisions by its readers or subscribers. Financiers are cautioned that they might lose all or a part of their financial investment when investing in stocks. For present services carried out FNM has actually been compensated forty 6 hundred dollars for news coverage of the current news release released by Pressure BioSciences, Inc. by the Business. FNM HOLDS NO SHARES OF ANY BUSINESS NAMED IN THIS RELEASE.
This release contains “positive statements” within the meaning of Section 27 A of the Securities Act of 1933, as amended, and Section 21 E the Securities Exchange Act of 1934, as amended and such positive statements are made pursuant to the safe harbor arrangements of the Personal Securities Lawsuits Reform Act of1995 You are warned that such declarations are subject to a plethora of risks and unpredictabilities that might cause future situations, events, or results to vary materially from those forecasted in the positive statements, including the threats that actual results might differ materially from those predicted in the positive declarations as a result of numerous elements, and other risks identified in a business’s annual report on Type 10- K or 10- KSB and other filings made by such business with the Securities and Exchange Commission.
Media Contact e-mail: [email protected]